Forty-one horses were treated for atrial fibrillation (AF) with 22 mg/kg quinidine sulfate via nasogastric tube every 2 hours until conversion t o sinus rhythm, a cumulative dose of 88 to 132 mg/kg had been administered in 2-hour increments, or the horse had adverse or toxic effects from the drug. Treatment intervals were prolonged t o every 6 hours if conversion had not occurred. Digoxin was administered before treatment if the horse had a fractional shortening 227% (3 horses), was prone t o tachycardia (resting heart rate 260 beats/min) (1 horse), or had a previous history of sustained tachycardia of over 100 beats/min during prior conversion (3 horses). Digoxin was administered during day 1 of quinidine sulfate treatment if the horse developed a sustained tachycardia of over 100 beats/min during treatment (1 1 horses) or on day 2 if conversion had not occurred (7 horses). Plasma quinidine concentrations within trial fibrillation (AF) is the most common ar-A rhythmia affecting performance in Conversion to sinus rhythm usually results in horses returning to their prior performance level. [1][2][3][4][6][7][8][9]14,17,[19][20][21][22][23][24][25][26][27] Quinidine sulfate is the drug of choice for conversion of horses with AF to sinus rhythm and is most successful when the duration of AF is short (less than 4 months), murmurs auscultated are less than grade III/ VI intensity, the resting heart rate is 560 beats/min, and there are no signs of congestive heart fail~re.'-~.~-ntravenous quinidine gluconate therapy 9. I 3 I 7.20-26 I has also been used successfully, particularly in horses with recent onset AF.3363'4,25-2x H orses with longer (>2 months) suspected duration of AF are less likely to convert to sinus rhythm with intravenous quinidine gluconate therapy.6 The success rate for conversion to sinus rhythm with quinidine sulfate therapy also decreases as the suspected duration of the arrhythmia increases.2 A standard treatment protocol for adult horses with AF is the administration of 10 g quinidine sulfate every 2 hours via nasogastric tube, until conversion to sinus rhythm occurs, a total dose of 40 to 60 g has been administered, or toxic signs are noIf conversion does not occur, this process can be repeated on days 2 and 3 . The use ofa test dose of 5 to 10 g quinidine sulfate before initiating treatment for AF has been r e p~r t e d .~-~.~.~~' l ' , e test dose is administered on the day preceding treatment or 2 hours before beginning treatment. If no adverse reactions are observed, quinidine sulfate therapy is continued at 10 g via nasogastric tube every 2 hours.Plasma quinidine concentration in horses peaks at 13 1 minutes after a single oral 10-g dose of quinidine sulfate (range, 45 to 180 minute^).^' The plasma-totissue distribution phase is thought to occur rapidly (within 30 minutes) in all domestic animal^.^'.^' Therefore, the administration of 10 g quinidine sulfate via nasogastric tube every 2 hours allows for stepwise titration of the drug in the horse, while monitoring carefully for adverse reac...